Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

TG Therapeutics, Inc. (NKB2.F)

35.26
+0.90
+(2.63%)
At close: April 25 at 8:06:17 AM GMT+2
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
577,690
329,587
193,572
379,629
Total Liabilities Net Minority Interest
355,326
169,085
134,985
142,476
Total Equity Gross Minority Interest
222,364
160,502
58,587
237,153
Total Capitalization
466,793
260,620
129,722
303,941
Common Stock Equity
222,364
160,502
58,587
237,153
Capital Lease Obligations
9,290
10,677
11,925
11,284
Net Tangible Assets
222,364
159,703
57,788
236,354
Working Capital
475,680
264,223
115,073
265,581
Invested Capital
466,793
260,620
129,722
304,916
Tangible Book Value
222,364
159,703
57,788
236,354
Total Debt
253,719
110,795
83,060
79,047
Net Debt
64,535
7,185
--
--
Share Issued
155,777.29
151,465.60
146,426.70
143,292.04
Ordinary Shares Number
155,777.29
151,424.29
146,385.39
143,250.73
Treasury Shares Number
--
41.31
41.31
41.31
12/31/2021 - 10/23/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers